Advertisement

Related Videos

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Mark Sculpher, PhD: How Do We Assess the Value of Cancer Drug Optimization?

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Advertisement

Advertisement




Sep
29
Today In Oncology
Long-Term Disease Control From SBRT Equal to Surgery in Localized Prostate Cancer
Cancer Statistics 2026: What Every Medical Oncologist Should Know
Short-Course SBRT Better Preserves Physical Function Before Pancreatic Cancer Surgery
Ultra-Low-Dose Radiation Therapy May Relieve Bone Pain From Multiple Myeloma
New Prognostic Model May Improve Risk Classification in Metastatic Clear Cell RCC
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo